Designing Growth Strategies is in our DNA

Psoriasis Treatment Market Size, Share & Industry Analysis, By Drug Class (TNF Inhibitors, Interleukin Inhibitors [IL-17, IL-23/p19, and IL-12/23 p40 Inhibitors], PDE4 Inhibitors, JAK Inhibitors, and Corticosteroids), By Indication (Plaque Psoriasis, Psoriatic Arthritis, Guttate Psoriasis, and Inverse Psoriasis), By Product Type (Biologics and Non-Biologics), By Route of Administration (Oral, Parenteral/Systemic, and Topical), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Specialty Pharmacies), and Regional Forecast, 2026-2034

Last Updated :September 21, 2026 | Format:PDF | Report ID: 100600

 

Request for Customization

man icon
Mail icon
Mail icon
Get 30-60 Hours of FREE Customization on this Report
Company Mapping:

Additional company profiling and benchmarking

Competitive Intelligence:

Advanced competitive landscape assessment

Segment Broadening:

Expanded segment-level coverage

Use-Case Analysis:

Tailored application and end-user evaluation

Extended Study Period:

Extended forecast and historical period

Geographic Granularity:

More detailed regional and country-level insights

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
  • 2021-2034
  • 2025
  • 2021-2024
  • 190